Ensign Group Past Earnings Performance
Past criteria checks 5/6
Ensign Group has been growing earnings at an average annual rate of 14.3%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 14.6% per year. Ensign Group's return on equity is 16.2%, and it has net margins of 7%.
Key information
14.3%
Earnings growth rate
13.1%
EPS growth rate
Healthcare Industry Growth | 8.5% |
Revenue growth rate | 14.6% |
Return on equity | 16.2% |
Net Margin | 7.0% |
Last Earnings Update | 31 Dec 2024 |
Recent past performance updates
Recent updates
Ensign Group (NASDAQ:ENSG) Might Have The Makings Of A Multi-Bagger
Feb 11What Is The Ensign Group, Inc.'s (NASDAQ:ENSG) Share Price Doing?
Jan 29The Ensign Group, Inc. (NASDAQ:ENSG) Not Lagging Market On Growth Or Pricing
Jan 11Is There An Opportunity With The Ensign Group, Inc.'s (NASDAQ:ENSG) 27% Undervaluation?
Dec 04Ensign Group: Expensive Despite Excellent Growth Prospects
Nov 18Ensign Group (NASDAQ:ENSG) Has A Pretty Healthy Balance Sheet
Nov 14The Ensign Group, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Oct 27The Ensign Group, Inc.'s (NASDAQ:ENSG) P/E Still Appears To Be Reasonable
Sep 27Is Now An Opportune Moment To Examine The Ensign Group, Inc. (NASDAQ:ENSG)?
Sep 09Does Ensign Group (NASDAQ:ENSG) Have A Healthy Balance Sheet?
Jul 29Getting In Cheap On The Ensign Group, Inc. (NASDAQ:ENSG) Might Be Difficult
Jun 18Ensign Group: Priced On Asset Growth, Supported By Fundamentals
Jun 12What Is The Ensign Group, Inc.'s (NASDAQ:ENSG) Share Price Doing?
May 30Shareholders Will Most Likely Find The Ensign Group, Inc.'s (NASDAQ:ENSG) CEO Compensation Acceptable
May 10Earnings Update: The Ensign Group, Inc. (NASDAQ:ENSG) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
May 05Is There An Opportunity With The Ensign Group, Inc.'s (NASDAQ:ENSG) 37% Undervaluation?
Apr 17Ensign Group (NASDAQ:ENSG) Seems To Use Debt Quite Sensibly
Mar 11Revenue & Expenses Breakdown
How Ensign Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 24 | 4,260 | 298 | 249 | 0 |
30 Sep 24 | 4,109 | 240 | 299 | 0 |
30 Jun 24 | 3,968 | 225 | 293 | 0 |
31 Mar 24 | 3,853 | 218 | 290 | 0 |
31 Dec 23 | 3,729 | 209 | 283 | 0 |
30 Sep 23 | 3,559 | 248 | 218 | 0 |
30 Jun 23 | 3,388 | 240 | 205 | 0 |
31 Mar 23 | 3,199 | 234 | 189 | 0 |
31 Dec 22 | 3,025 | 225 | 176 | 0 |
30 Sep 22 | 2,909 | 213 | 175 | 0 |
30 Jun 22 | 2,808 | 204 | 173 | 0 |
31 Mar 22 | 2,714 | 196 | 172 | 0 |
31 Dec 21 | 2,627 | 195 | 166 | 0 |
30 Sep 21 | 2,563 | 192 | 157 | 0 |
30 Jun 21 | 2,494 | 188 | 151 | 0 |
31 Mar 21 | 2,440 | 179 | 145 | 0 |
31 Dec 20 | 2,403 | 170 | 143 | 0 |
30 Sep 20 | 2,334 | 152 | 141 | 0 |
30 Jun 20 | 2,247 | 131 | 135 | 0 |
31 Mar 20 | 2,155 | 111 | 128 | 0 |
31 Dec 19 | 2,037 | 92 | 123 | 0 |
30 Sep 19 | 1,728 | 58 | 106 | 0 |
30 Jun 19 | 1,730 | 56 | 102 | 0 |
31 Mar 19 | 1,734 | 58 | 96 | 0 |
31 Dec 18 | 1,755 | 59 | 91 | 0 |
30 Sep 18 | 1,991 | 77 | 95 | 0 |
30 Jun 18 | 1,948 | 71 | 90 | 0 |
31 Mar 18 | 1,900 | 61 | 85 | 0 |
31 Dec 17 | 1,598 | 17 | 74 | 0 |
30 Sep 17 | 1,795 | 48 | 73 | 0 |
30 Jun 17 | 1,751 | 45 | 71 | 0 |
31 Mar 17 | 1,713 | 44 | 73 | 0 |
31 Dec 16 | 1,655 | 50 | 69 | 0 |
30 Sep 16 | 1,595 | 45 | 72 | 0 |
30 Jun 16 | 1,518 | 48 | 71 | 0 |
31 Mar 16 | 1,419 | 49 | 67 | 0 |
31 Dec 15 | 1,342 | 55 | 64 | 0 |
30 Sep 15 | 1,246 | 53 | 59 | 0 |
30 Jun 15 | 1,155 | 49 | 55 | 0 |
31 Mar 15 | 1,094 | 38 | 51 | 0 |
31 Dec 14 | 1,027 | 36 | 48 | 0 |
30 Sep 14 | 988 | 38 | 47 | 0 |
30 Jun 14 | 956 | 39 | 45 | 0 |
31 Mar 14 | 926 | 50 | 43 | 0 |
Quality Earnings: ENSG has high quality earnings.
Growing Profit Margin: ENSG's current net profit margins (7%) are higher than last year (5.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ENSG's earnings have grown by 14.3% per year over the past 5 years.
Accelerating Growth: ENSG's earnings growth over the past year (42.3%) exceeds its 5-year average (14.3% per year).
Earnings vs Industry: ENSG earnings growth over the past year (42.3%) exceeded the Healthcare industry 20%.
Return on Equity
High ROE: ENSG's Return on Equity (16.2%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/22 17:42 |
End of Day Share Price | 2025/02/21 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
The Ensign Group, Inc. is covered by 15 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Kevin Campbell | Avondale Partners |
Ishan Majumdar | Baptista Research |
Tao Qiu | Berenberg |